Bei Akademie registrieren
Amgen, US0311621009

Amgen stock biotech group trades pre-market at EUR 387.20

Published on 10/19/2026 at 07:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Amgen develops medicines for patients with serious illnesses. At Lang & Schwarz the stock trades pre-market at EUR 387.20 on October 19, 2026.

Company profile and opening context

  • Amgen develops and sells medicines for patients with serious illnesses.
  • The home market for Amgen is the S&P 500 in the United States.
  • Amgen stock trades pre-market at Lang & Schwarz at EUR 387.20 at 7:43 a.m. CEST on October 19, 2026.
Architektonischer 3D-Render eines modernen Biopharma-Gebäudes mit Glasfassade und gepflegter Grünanlage
Amgen Inc. (ISIN US0311621009) passend visualisiert als architektonischer Render einer modernen Biopharma-Forschungsanlage, Illustration mit AI erstellt.

The biotechnology company develops medicines for patients with serious illnesses, according to Amgen. Amgen stock trades pre-market at EUR 387.20 at 7:43 a.m. CEST at Lang & Schwarz on October 19, 2026.

Ahead of the Xetra open

The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Amgen stock.

Business and market context

Amgen develops and sells medicines for patients with serious illnesses, as described in its investor materials. Market context: Market report S&P 500.

More news and analysis on Amgen stock

Disclaimer...
en | US0311621009 | AMGEN | boerse | 70357475 | bgmi